PCNA和CD44v6在鼻咽癌组织中的表达及其相互关系  

The expression of PCNA and CD44V6 in nasopharyngeal carcinoma and their relationship

作　　者：蔡良真[1] 支梅芬[1] 何文艳[1] 

机构地区：[1]广东医学院附属医院肿瘤中心,广东湛江524000

出　　处：《中国医药导报》2010年第28期16-18,共3页China Medical Herald

基　　金：2008年度湛江市第六批科技攻关项目(课题名称:PCNA和CD44v6和Ki67在鼻咽癌中的表达及其临床意义;项目编号:008C06016)

摘　　要：目的:研究PCNA和CD44v6在鼻咽癌的表达及其相互关系。方法:应用免疫组化S-P法检测23例慢性鼻咽炎、62例鼻咽癌组织(38例伴有淋巴结转移)中PCNA和CD44v6的表达。结果:62例鼻咽癌组织PCNA和CD44v6阳性表达率分别为69.3%、77.4%,与23例慢性鼻咽炎PCNA、CD44v6阳性率比较,差异有统计学意义(P<0.05)。鼻咽癌转移组和非转移组PCNA的阳性率分别为68.4%、70.8%,差异无统计学意义(P>0.05);转移组CD44v6阳性率要高于非转移组,阳性率分别为89.4%、58.3%,差异有统计学意义(P<0.05)。PCNA和CD44v6共同阳性表达有39例,共同阴性表达10例,两者表达呈正相关(r=0.436,P<0.01)。结论:PCNA和CD44v6在鼻咽癌组织中存在高表达,在鼻咽癌的发生、发展中起着重要作用。Objective： To investigate the expression of PCNA and CD44v6 in nasopharyngeal carcinoma （NPC） and their relationship. Methods： the expression of PCNA and CD44v6 were detected in 23 cases chronic nasopharyngitis and 62 NPCs （38 cases with lymph node metastases） by S-P immunohistochemical method. Results： The positive expression rates of PCNA and CD44V6 were 69.3% and 77.4% in 65 NPCs,showing statistical difference from those of 23 cases chronic nasopharyngitis （P 0.05）. The positive expression rates of PCNA in metastasis group and non-metastasis group were 68.4%,70.8%, there was no statistical significance （P0.05）; The positive expression rates of CD44v6 in metastasis group and non-metastasis group were 89.4%,58.3%,there was statistical significance （P0.05）. PCNA and CD44V6 were expressed positively in 39 cases,while being expressed negatively in 10 cases, showing positive correlation between them （r=0.436, P0.01）. Conclusion： PCNA and CD44v6 is high expression in NPCs, playing important roles in the occurrence and development of NPC.

关 键 词：鼻咽癌 PCNA CD44V6 转移 

分 类 号：R739.6[医药卫生—肿瘤]